Botulinum neurotoxin (BoNT) is a potent biological substance used to treat neuromuscular and pain disorders. Both BoNT type A and BoNT type E display high-affinity uptake into motor neurons and inhibit exocytosis through cleavage of the synaptosome-associated protein of 25 kDa (SNAP25). The therapeutic effects of BoNT͞A last from 3 to 12 months, whereas the effects of BoNT͞E last less than 4 weeks. Using confocal microscopy and site-specific mutagenesis, we have determined that the protease domain of BoNT͞A light chain (BoNT͞ A-LC) localizes in a punctate manner to the plasma membrane, colocalizing with the cleaved product, SNAP25 197. In contrast, the short-duration BoNT͞E serotype is cytoplasmic. Mutations in the BoNT͞A-LC have revealed sequences at the N terminus necessary for plasma membrane localization, and an active dileucine motif in the C terminus that is likely involved in trafficking and interaction with adaptor proteins. These data support sequence-specific signals as determinants of intracellular localization and as a basis for the different durations of action in these two BoNT serotypes.
B
otulinum neurotoxins (BoNTs) are the most potent of all biological substances (1) . Although BoNTs are well publicized as a potential biological weapon and as the causative agents in clinical botulism, the potency and myorelaxant actions of BoNTs have been exploited clinically in more than 100 indications, including muscle hyperactivity in cerebral palsy and cervical dystonia, migraines, myofacial pain, and focal hyperhidrosis (2) (3) (4) (5) . These toxins are specific endoproteases that, collectively, target several distinct proteins in nerve terminals. Motor nerve terminals at neuromuscular junctions are particularly sensitive to these neurotoxins, resulting in a transient and reversible muscle relaxation through inhibition of acetylcholine release. The Clostridium neurotoxin family includes seven serotypes of BoNT (A-G), and a single form of toxin produced by Clostridium tetani (TeNT). These toxins consist of a heavy chain (HC, 100 kDa) and light chain (LC, 50 kDa) linked by a disulfide bond (6, 7) . The three-dimensional crystal structures of BoNT͞A (8) and BoNT͞B (9) have been resolved, providing a basis for understanding the structure͞function mechanism of BoNT action. The BoNT-LCs are zinc-dependent endoproteases that specifically cleave one of three soluble Nethylmaleimide-sensitive factor-attachment protein-receptor (SNARE) proteins (10) involved in synaptic vesicle docking and fusion at the nerve terminal (11) . The synaptosome-associated protein of 25 kDa (SNAP25) is cleaved at distinct sites near the C terminus by BoNT͞A (Q 197 -R 198 ) and BoNT͞E (R 180 -I 181 ), generating truncated SNAP25 197 (12) and SNAP25 180 (13) , respectively. A ratio of cleaved to intact SNAP25 of as little as 0.1 to 0.35 is sufficient to inhibit exocytosis (14, 15) .
BoNTs display long but variable durations of action that are serotype specific. The clinical therapeutic effect of BoNT͞A lasts approximately 3 months for neuromuscular disorders and 6-12 months for hyperhidrosis (16) . In cultured murine embryonic spinal cord cells treated with BoNT͞A, SNAP25 197 can be detected for more than 80 days (17) . Because SNAP25 206 and SNAP25 197 display similar half-lives (24 h) (6, 18), a prolonged persistence of BoNT͞A-LC within neurons has been suggested to be responsible for the long duration of action (17) . Interestingly, the half-lives of most endogenous and exogenous cellular proteins range in length up to a few days (19) . No explanation is readily available for the long duration of BoNT͞A-LC. Toxin may escape degradation pathways in neuronal cells through subcellular localization into specific cellular structures and͞or may be sequestered and protected through interactions with select cellular proteins. In the present study, we demonstrate that BoNT͞A-LC localizes to the plasma membrane of neuronal cells through signals present at the N and C termini of the protein. In contrast, BoNT͞E-LC, with the shortest duration of action, is cytoplasmic. These data provide insight toward the understanding of the long duration of action of BoNT͞A versus BoNT͞E at the neuromuscular junction.
Methods
Plasmids. The LCs of BoNT͞A (Allergan Hall A), and BoNT͞E (Beluga) were cloned in pQBI50 plasmids (Qbiogene, Carlsbad, CA) by PCR amplification of genomic DNA. Constructs expressing BoNT͞A-LC (LC͞A) and BoNT͞E-LC (LC͞E) with the GFP at the N terminus were generated: GFP-LC͞A and GFP-LC͞E. Truncations in the BoNT͞A-LC were as follows: GFP-LC͞A(⌬N8͞ ⌬C22) with 8 aa deleted from the N terminus and 22 aa from the C terminus, GFP-LC͞A(⌬N8) with 8 aa deleted from the N terminus, and GFP-LC͞A(⌬C22) with 22 aa deleted from the C terminus. The dileucine mutant, GFP-LC͞A(LL3AA) with L427A and L428A, was generated by site-directed mutagenesis (Stratagene) using GFP-LC͞A as a template. Wild-type LC͞A and the mutants described above were cloned into pET-30b(ϩ) vectors containing polyhistidine affinity tags (Novagen). rLC͞A, rLC͞ A(⌬N8͞⌬C22), and rLC͞A(⌬C22) were generated by PCR from genomic DNA. rLC͞A(LL3AA) was generated by site-directed mutagenesis using rLC͞A as a template.
Cell Culture and Transfection. The rat pheochromocytoma cell line PC12 was obtained from ATCC (CRL-1721) and was cultured in collagen IV-coated dishes (BD Biocoat, Bedford, MA) in RPMI medium 1640 (Invitrogen) containing 10% heat-inactivated horse serum, 5% FBS, 10 mM Hepes, 1 mM sodium pyruvate, 0.45% glucose, and 50 units of penicillin͞50 g of streptomycin. Differentiation of PC12 into sympathetic-like neurons was achieved in differentiation medium containing RPMI medium 1640, N2 supplement, sodium pyruvate, glucose, 0.5% BSA, and penicillin͞ streptomycin supplemented with nerve growth factor (NGF; Harlan, Indianapolis) at 50 ng͞ml. Transfection was performed by using Lipofectamine 2000 (Invitrogen). Cells were plated 1 day before transfection at a density of 1.2 ϫ 10 6 cells per 60-mm dish and were transfected with 10 g of DNA in 25 l of Lipofectamine mixed for 20 min in Opti-MEM medium (Invitrogen). The DNA mixture was added to cells in regular culture medium and was incubated overnight. Cells were then differentiated in NGF-containing medium and visualized with an inverted fluorescence microscope (Leica, Bannockburn, IL). Typical transfection efficiencies were 35-50%.
Antibodies, Immunoprecipitation, and Western Blot Analysis. Antibodies to GFP were monoclonal 3E6 (Qbiogene) and rabbit polyclonal (Santa Cruz Biotechnology). Antibody to SNAP25 was SMI-81 (Sternberger, Lutherville, MD). Rabbit polyclonal antibodies that specifically recognize the BoNT͞A cleavage product, SNAP25 197 , and BoNT͞E product, SNAP25 180 , were custom generated for Allergan. These antibodies do not crossreact with the uncleaved substrate SNAP25 206 .
For immunoprecipitation studies, cells were washed with PBS and lysed in 50 mM Hepes buffer containing 150 mM NaCl, 1.5 mM MgCl 2 , 10% glycerol, 1 mM EGTA, and 1% Triton X-100 plus Complete protease inhibitors (Roche, Switzerland). Precleared lysates were incubated with antibody 3E6 at 4°C for 2 hr. Immobilized protein G (Pierce) was then added and incubated for 1 hr at 4°C. Beads were washed in lysis buffer, centrifuged, resuspended in sample loading buffer, and boiled before electrophoresis in Criterion Tris⅐HCl 4-15% gels (Bio-Rad). Protein expression was analyzed by Western blotting. Cells were washed and lysed in the 1% Triton X-100͞50 mM Hepes buffer for 1 hr at 4°C. Sample loading buffer was added to the cleared lysate and the protein was separated in Criterion Tris⅐HCl 4-15% gels. Proteins were transferred to poly(vinylidene difluoride) (PVDF) membranes, blocked with 1% milk in TBST (25 mM Tris⅐HCl, pH 7.2͞150 mM NaCl͞0.1% Tween 20) , and incubated with the primary antibody followed by the corresponding secondary antibody. Blots were developed with SuperSignal chemiluminescence substrates (Pierce). When both full-length and cleaved SNAP25 were detected in the same Western blot with SMI-81 antibody, protein was extracted from cells with chloroform͞methanol (20) . Proteins were separated by SDS͞ PAGE and blotted as described above.
Immunocytochemistry. Transfected and control PC12 cells were fixed with 4% paraformaldehyde and washed with PBS. Cells were permeablized in 1% Triton X-100 in PBS followed by methanol at Ϫ20°C. Blocking was achieved by incubating the cells in 100 mM glycine for 30 min followed by a 30-min incubation in 0.5% BSA͞PBS. Staining was performed with the following primary antibodies: polyclonal antibody to GFP (Santa Cruz Biotechnology), monoclonal antibody to SNAP25 206 (StressGen Biotechnologies, Victoria, Canada), monoclonal antibody to SNAP25 197 (Allergan), and purified polyclonal antibody to SNAP25 180 (Allergan). Primary antibodies were incubated at room temperature for 2 hr in a humidified chamber. After washing, Alexa Fluor (480 or 568) -conjugated antibodies (Molecular Probes) were applied to the samples at 1:200 dilution and incubated at room temperature for 1 hr. Stained dishes were mounted with Vectashield solution (Vector Laboratories) and coverslipped. Images were obtained with a Leica confocal microscope using appropriate laser settings. Leica colocalization software was used to quantitate double-stained samples.
Inhibition of Exocytosis. PC12 cells were transfected with plasmid constructs encoding GFP or GFP-LC fusion proteins and were selected with G418 for 2-3 days. The day before the assay, cells were plated at 2 ϫ 10 -free PBS. Exocytosis was induced by incubating the cells at 37°C for 15 min in release buffer (51 mM NaCl͞100 mM KCl͞0.5 mM MgCl 2 ͞ 2.2 mM CaCl 2 ͞5.6 mM D-glucose͞15 mM Hepes, pH 7.4). A calcium-free buffer was used to measure basal release. After release, 500 l of the buffer was added to 5 ml of Ready Protein Scintillation mixture (Beckman). Unreleased [ 3 H]norepinephrine remaining in the cells was quantified by removing the cells with trypsin and adding them to fresh tubes containing the scintillation mixture. Samples were measured and data were expressed as percent release (dpm released divided by total dpm).
Production of Recombinant Proteins and Activity Assay Toward
SNAP25. Recombinant BoNT͞A-LC constructs (wild-type and mutants) were transformed into BL21-CodonPlus (DE3)-RIL Escherichia coli cells (Stratagene). Cultures were grown to an OD 600 of 0.6-0.7 and then induced with 0.5 mM isopropyl ␤-D-thiogalactoside (IPTG) for 2 hr. Recombinant proteins were purified by affinity chromatography with BD Talon resin (BD Biosciences Clontech, Palo Alto, CA)). Purity of the proteins was assessed by SDS͞PAGE. Activity of the rLC͞A, rLC͞A(AA), rLC͞A(⌬C22), and rLC͞A(⌬N8͞⌬C22) was measured with an ELISA. Briefly, a recombinantly produced biotinylated substrate corresponding to SNAP25 was immobilized on a streptavidin-coated microtiter plate (Pierce). The appropriate rLC͞A constructs and 900-kDa BoNT͞A complex as a control were added to substrate-coated plates. Protease activity was determined by quantitating the formation of SNAP25 with a polyclonal antibody specific for the cleaved product (Allergan). Statistical modeling and parameter comparisons between data sets were carried out by using an extra-sum-of-squares F test (21, 22) .
Results
BoNT͞A-LC Colocalizes with SNAP25 at the Plasma Membrane. To study the subcellular localization of BoNT-LCs, PC12 cells were transfected with plasmids encoding either GFP or a GFP-LC fusion. Imaging of GFP-expressing cells by using confocal microscopy demonstrated a homogeneous distribution of fluorescence throughout the cell (Fig. 1A) . In contrast, the fluorescence of GFP-LC͞A was localized in a punctate fashion along the plasma membrane of the cell body and neurites (Fig. 1B) . Expression levels of GFP-LC͞A were 10-to 20-fold lower than GFP alone, probably because of the unfavorable codon bias of clostridial genes (23) expressed in mammalian cells; however, protein analysis demonstrated single bands of the correct molecular weight for GFP and GFP-LC͞A (Fig. 1C) . Western blot analysis of cell lysates of nonselected cells probed with antibodies specific to SNAP25 197 or the N terminus of SNAP25 demonstrated that GFP-LC͞A is proteolytically active (Fig. 1D) . Expressed GFP-LC͞A in G418-selected cells inhibited [ 3 H]norepinephrine release significantly (Fig. 1E) , similar to cells electroporated with 0.5 nM BoNT͞A (Fig.  5 , which is published as supporting information on the PNAS web site). The punctate plasma membrane distribution of GFP-LC͞A is similar to that of its substrate, SNAP25, in neuronal cells (24) . In cells transfected with GFP-LC͞A there was no intact SNAP25 206 visible by immunocytochemistry (Fig. 6 , which is published as supporting information on the PNAS web site). Staining of cells with a monoclonal antibody specific for SNAP25 197 , and polyclonal antibodies to GFP, and merging the fluorescent signals from confocal microscopy, revealed colocalization of SNAP25 197 and GFP-LC͞A ( Fig. 2A) . Analysis of several fields (n ϭ 8) demonstrated that 76 Ϯ 9% of GFP-LC͞A colocalizes with SNAP25 197 and 60 Ϯ 10% of SNAP25 197 colocalizes with GFP-LC͞A. This result is in contrast to the data obtained staining for GFP and SNAP25 206, (Fig. 2B ) in which 19 Ϯ 5% of GFP colocalized with SNAP25 206 and 26 Ϯ 7% of SNAP25 206 colocalized with GFP. These data demonstrate the localization of both BoNT͞A-LC and SNAP25 197 to a common plasma membrane compartment.
Despite sharing SNAP25 as a common substrate with BoNT͞ A-LC, BoNT͞E-LC displayed a completely different subcellular distribution (Fig. 2C) . GFP-LC͞E was visualized in the cytoplasm, with few cells displaying plasma membrane fluorescence, and was mainly absent from nuclei. In addition, cells expressing GFP-LC͞E in differentiation media were rounded with very few, short, and thin neurites compared with untransfected cells in the same dish. These results are consistent with reports in the literature of PC12 cells transfected with BoNT͞E-LC and differentiated with staurosporine (24) . The proteolytic activity of GFP-LC͞E was confirmed by Western blot analysis of SNAP25 206 and SNAP25 180 (Fig. 1D) and inhibition of neurotransmitter release from PC12 cells (Fig. 1E) . Immunostaining with an antibody specific for the BoNT͞E-LC cleavage product, SNAP25 180 , revealed a substantially different localization pattern. Fluorescence was observed primarily in the cytoplasm, to a lesser extent at the plasma membrane, and was absent from nuclei (Fig. 2C) . It has previously been hypothesized that cleavage of 26 aa from SNAP25 by BoNT͞E-LC hastens the removal of nonfunctional SNAP25 180 from the plasma membrane, allowing the incorporation of newly synthesized SNAP25 206 (6) . Our work provides experimental evidence of a shift in localization of SNAP25 from the plasma membrane to the cytosol after being cleaved to SNAP25 180 . Examination of more than 15 fields demonstrated that 73 Ϯ 8% of GFP-LC͞E colocalized with SNAP25 180 , and 51 Ϯ 15% of SNAP25 180 colocalized with GFP-LC͞E. The cellular distribution of GFP-LC͞E and SNAP25 180 is in marked contrast to the observed distribution for either GFP-LC͞A or SNAP25 197 .
Localization Signals Are Present in BoNT͞A-LC Sequence. In an attempt to identify the presence of localization signals in BoNT͞A-LC, several truncated variants were prepared. A truncated form of BoNT͞A-LC, comprising residues Tyr-9 to Leu-415 (⌬N8͞⌬C22) was reported as the minimal essential domain of the endoprotease with a structure (PDB structure ID code 1E1H) similar to the BoNT͞A-LC structure in the holotoxin (8) , and retaining a diminished catalytic activity toward SNAP25 (25) . Deleted amino acids are depicted in yellow in the ribbon structure shown in Fig. 3A and Fig. 7 , which is published as supporting information on the PNAS web site. GFP-LC͞A (⌬N8͞⌬C22) no longer localized to the plasma membrane; instead, fluorescence appeared in perinuclear structures as well as throughout the cytoplasm (Fig. 3B) . The protein was not degraded as shown by Western blot analysis (Fig.  3C ) and retained minimal activity with respect to cleavage of SNAP25 (Fig. 3D) . These data suggest that signals involved in directing BoNT͞A-LC to the plasma membrane may reside within the deleted N and͞or C termini (Fig. 3A) . Further analysis of the sequence revealed the presence of a putative dileucine motif (D͞EXXXLL) at the C terminus (Fig. 3A, in red) that was present only in the BoNT͞A serotype (FEFYKLL) ( Table 1 and Fig. 8 , which is published as supporting information on the PNAS web site). Targeting and trafficking of proteins to different compartments depend on sorting signals contained within the protein (26, 27) . These signals interact with specific recognition molecules, which are components of membrane-bound transport intermediates (28) . Direct or indirect interaction of dileucine motifs with adaptor protein (AP) complexes, such as AP1, AP2, and AP3, has been demonstrated for several proteins. Most reported proteins containing identified dileucine motifs are transmembrane proteins (Table 1) , with the Nef protein of primate lentiviruses being the only nontransmembrane protein known to traffic by means of a dileucine motif (26, (29) (30) (31) .
BoNT͞A-LC Contains an Active Dileucine Motif. Mutation of the leucines into alanines has been shown to disrupt the motif and thereby affect interaction with AP adaptors, protein internalization, and͞or intracellular localization. For example, mutation of the motif present in VAMP4 affects its steady-state distribution, with a large proportion of VAMP4 being found in peripheral structures in addition to the normal trans-Golgi network (TGN) distribution (32) . A dileucine to dialanine GFP-LC͞A(AA) mutant (L427A and L428A) was expressed in PC12 cells (Fig. 3C) , revealing that disruption of the dileucine motif caused changes in the steady-state distribution at the plasma membrane. GFP-LC͞A(AA) displayed a periplasmalemmal distribution with some protein in the cytoplasm, suggesting that the protein can reach the target membrane but may be loosely anchored (Fig. 3E) . A similar pattern of localization (Fig.  3G ) was observed when GFP-LC͞A(⌬C22), lacking 22 C-terminal amino acids, was expressed, suggesting that the primary localization signal present at the C terminus is the dileucine motif. Localization changes for both LC͞A C-terminal mutants are consistent with reports demonstrating that mutations of dileucine motifs yield proteins that have a loose association with the membrane due to disrupted interactions with complexing proteins (32) . Both GFP-LC͞A(⌬C22) and GFP-LC͞A(AA) mutants were expressed in PC12 cells at higher levels than GFP-LC͞A (Fig. 3 C and F) . Proteolysis of SNAP25 could be detected in the transfected cells at slightly lower levels than seen with wild-type LC͞A (Fig. 3 D and I) .
Because neither truncation (⌬C22) nor mutation (LL 3 AA) of the C terminus produced the same effect as the double-truncation mutant (⌬N8͞⌬C22), we postulated that signals important for plasma membrane targeting were also present at the N terminus. A GFP-LC͞A(⌬N8) with eight N-terminal amino acids removed was expressed in differentiated PC12 cells (Fig. 3F) . A complete loss of plasma membrane localization was observed (Fig. 3H) , with fluorescence dispersed throughout the cytoplasm and nuclear exclusion. In Ϸ5% of these cells, localization was similar to the GFP-LC͞A (⌬N8͞⌬C22) mutant. The GFP-LC͞A(⌬N8) mutant was expressed at lower levels than GFP-LC͞A (Fig. 3F ) and appeared less efficient at cleaving SNAP25 (Fig. 3I) . The sequence of the first eight amino acids at the N terminus is different between serotype A and E, as shown in the sequence alignment in Fig. 8 . These data (Fig. 4A) . Cellular inhibition of neurotransmitter release correlated well with the intracellular SNAP25 197 Western blot data; however, similarities and differences in activity are not accurately quantifiable in these cellular analyses, because of variable expression levels in cells transfected with different plasmid constructs. To further characterize their proteolytic activities, BoNT͞A-LC mutants were expressed in E. coli as polyhistidinetagged fusion proteins (Fig. 4B) . Protease activity was analyzed in an ELISA using a substrate corresponding to SNAP25 and SNAP25 197 -specific antibodies (Fig. 4C) . Statistical modeling and parameter comparisons between data sets were carried out by using an extra-sum-of-squares F test. No differences were observed for the activity of BoNT͞A-LC with affinity tags at the N or C terminus and data are presented as a combination. Surprisingly, analysis of the various recombinant LC͞A constructs revealed that the dialanine mutant (rLC͞A(AA)) was 26-fold less active than the wildtype LC͞A construct. Upon truncation of the 22-aa C-terminal tail containing the dileucine motif [rLC͞A(⌬C22)], the catalytic activity was significantly reduced 3-fold compared with the dialanine mutant. These results are interesting because removal of the C-terminal tail has minimal impact beyond the substitution of two amino acids. When both the N and C termini were deleted, rLC͞A(⌬N8͞⌬C22), the catalytic activity was further reduced (greater than 600-fold reduction compared with wild-type LC͞A). These results demonstrate that the diminished cellular LC activity can be attributed in part to decreased catalytic activity. In addition, a decrease in cellular SNAP25 cleavage by LC͞A mutants with reduced membrane association may also be due, in part, to a lack of localization with SNAP25 at the plasma membrane. BoNT͞ A-LC catalytic activity is not needed for plasma membrane localization because an inactive LC͞A [GFP-LC͞A(H227Y)] with intact N and C termini localizes to the plasma membrane. Reduced activity of the rLC mutants may be due to changes in the protein structure resulting in changes in the catalytic activity, and these findings warrant further protein structure͞function analysis.
Discussion
This study demonstrates that BoNT͞A-LC associates with the plasma membrane of neuronal cells through signals present in the primary sequence of the protein. It also demonstrates that BoNT͞ A-LC resides in close proximity to SNAP25 197 at the plasma membrane, whereas BoNT͞E-LC and SNAP25 180 reside in the cytoplasm. This difference is striking because the duration of action of BoNT serotypes in animals (33, 34) and cell culture models (17, 18) is generally accepted to be BoNT͞A Ͼ Ͼ BoNT͞E. Direct comparisons of the duration of action of BoNT͞A and BoNT͞E in human extensor digitorum brevis muscles showed that BoNT͞E-treated muscles were fully recovered after 30 days, whereas BoNT͞A muscles remained fully inhibited by 90 days (35) . This distinct subcellular localization could make BoNT͞E-LC more accessible to degradation in the neuron, whereas BoNT͞A-LC may be partially protected from degradation by localizing to a slow recycling compartment at the plasma membrane.
The data presented also demonstrate that a signal for plasma membrane localization resides within the first eight amino acids at the N terminus of LC͞A; alternatively, these amino acids may constitute an important structural element within the protein.
Moreover, an active dileucine motif present at the C terminus of BoNT͞A-LC has been identified. The change in localization due to disruption or deletion of the dileucine motif may be more relevant when exogenous toxin is administered to neurons because of the role of this motif in protein trafficking, since BoNT͞A is trafficked intracellularly through acidic endosomes. Acidification of the vesicle is responsible for a conformational change of the translocation domain facilitating delivery of BoNT͞A-LC to the cytoplasm (3, 4, 36) . It is hypothesized that the C terminus of BoNT͞A-LC may be accessible for interaction with adaptor proteins and BoNT͞A-LC may be directed to the plasma membrane in this manner. Examples of the role of dileucine motifs in the retargeting process from acidic endosomes have been reported. For example, the dileucine motif of the insulin-regulated aminopeptidase (IRAP) plays a role in retargeting the protein from the acidic endosomes of the endocytic recycling compartment to the plasma membrane (37) . The dileucine motif is specific to serotype A and may play a role in trafficking of BoNT͞A-LC from the acidic endosomal compartment to the plasma membrane. Interestingly, BoNT͞C1 neurotoxin also causes a long inhibition of transmitter release (18) but lacks a dileucine motif at the C terminus and differs from serotype A in the first 8 aa at the N terminus (Fig. 8) . In a previous report, expression of a pEGFP͞BoNT͞C1-LC construct in HIT-T15 cells appeared to yield GFP fluorescence dispersed throughout the cell, including the nucleus (38) , similar to that what we have previously reported for BoNT͞B-LC. † Although shorter than serotype A (18), B and C1 do have a long duration of action in neuronal cells, supporting an alternative mechanism for these serotypes other than plasma membrane localization for the persistence of the endopeptidase activity. BoNT͞A-LC is unique in being a protein of bacterial origin containing a functional dileucine motif. These data support sequence-specific signals as determinants of intracellular localization and as a basis for the duration and toxicity differences between the two different botulinum neurotoxin serotypes. Elucidating the mechanism of the subcellular localization and trafficking of BoNTs within neurons will aid in understanding the long and variable duration of action of BoNT activity in neurons. We thank Li Zhang for providing the clostridial genomic DNA used for cloning, and Dr. George Sachs (University of California, Los Angeles) for assistance with confocal microscopy and scientific direction. We are also indebted to Todd Herrington for early studies on the motifs.
